Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 23, 1051-1058, August 1, 1963]
© 1963 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, P. B.
Right arrow Articles by Kruse, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, P. B.
Right arrow Articles by Kruse, P. F., Jr.

Response of Jensen Sarcoma Cell Cultures to Some Analogs, Homologs, and Peptides of Arginine, Ornithine, and Citrulline*

Pat B. White, Carroll W. Smith and Paul F. Kruse, Jr.

( Biomedical Division, The Samuel Roberts Noble Foundation, Inc., Ardmore, Oklahoma)

Previous studies with canavanine led to the present testing of the effects of canaline and other compounds related to arginine, ornithine, and citrulline on Jensen sarcoma cell cultures. Canaline inhibited proliferation of the tumor cells in vitro by 50 per cent at 0.1 mM concentration. The inhibition was not competitive with ornithine, but it was prevented by pyridoxal phosphate and glutamic acid semialdehyde. The toxicity of canaline probably rested, therefore, in "carbonyl-trapping" properties of its substituted hydroxylamine structure.

In related studies, the {alpha}-hydroxy and {alpha}-keto analogs of arginine could neither inhibit proliferation nor support it in the absence of arginine. Two lower and one higher (homoarginine) homologs of arginine were similarly ineffective, as were a number of other related compounds. Two lower homologs each of citrulline and ornithine and one higher (homocitrulline) of citrulline could not inhibit cellular proliferation appreciably.

In contrast to the above results with arginine analogs and homologs, several arginine-containing peptides and protamines not only could supplant arginine in the culture medium but also markedly stimulated proliferation. L-Prolyl-L-phenylalanyl-L-arginine and two protamines, clupeine and salmine, most stimulated proliferation, producing ca. 50 per cent more new cells than in control culture with free arginine. L-Valyl-L-arginine and L-prolyl-L-arginine supported proliferation but did not stimulate it appreciably. L-ß-Methylaspartyl-L-arginine supported proliferation but did not inhibit it. D-Alanyl-L-arginine could only partially spare the arginine requirement, while L-phenylalanyl-L-citrulline was incapable of replacing arginine.

* Portions of this study were presented at meetings of the Southwest Section, Am. Assoc. for Cancer Research, Oklahoma City, November, 1961, and the Tissue Culture Assoc., Washington, D.C., May, 1962.

Received 3/ 6/63.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1963 by the American Association for Cancer Research.